The tools we need

EVERYONE WANTS TO KNOW when we’ll be safe from COVID-19. The answer is we’re probably in for a long fight. We’ll face a persistent risk, maybe until we get a vaccine or even after. But that risk can be managed, and reduced, if we focus on helping those at the greatest threat of getting the disease.

Reliable tests for the presence of antibodies (which tell who has had the disease) will be very important.

Vous lisez un aperçu, inscrivez-vous pour en lire plus.

Plus de TIME

TIME15 min de lectureSociety
How Remdesivir Became The First And Biggest Hope For Treating COVID-19
Dr. George Diaz was at home in Edmonds, Wash., on Jan. 20 at 8:30 p.m., when his phone rang with news that he was both anticipating and dreading. On the line was his hospital’s infection-prevention manager, who had just received a call from the U.S.
TIME2 min de lectureSociety
A COVID-19 Vaccine Shows Promise In Early Study
IN MARCH, THE BIOTECH COMPANY Moderna became one of the first to begin testing an experimental COVID-19 vaccine in healthy human volunteers. Now, the company has reported positive results from a small Phase 1 study: Moderna said on May 18 that there
TIME1 min de lecture
For The Record
Approximate expected attendance at the 2020 Republican National Convention, set to be held in late August in Charlotte, N.C., according to a May 16 press release; Democrats have been weighing options for a possible virtual convention Number of ancien